Projects per year
- 450 - 500 out of 23,575 results
Search results
-
Active
Care and Repair: Rethinking Contemporary Curation for Conditions of Crisis
McDowell, T. (Primary Chief Investigator (PCI)), Antoinette, M. (Chief Investigator (CI)), McQuilten, G. (Chief Investigator (CI)) & Khan, R. (Partner Investigator (PI))
Australian Research Council (ARC)
31/12/24 → 30/12/27
Project: Research
-
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Webber, K. (Primary Chief Investigator (PCI))
23/12/24 → 22/12/29
Project: Research
-
Biochar production and properties for electric ironmaking
Strezov, V. (Primary Chief Investigator (PCI)), Jiang, Y. (Chief Investigator (CI)), Evans, T. (Partner Investigator (PI)) & Ching, T. (Project Manager)
20/12/24 → 20/12/29
Project: Research
-
A Phase 3 Randomized, Double-blind, 52-week Placebo Controlled Multi-center Study with a Double-blind 52-week Extension Period with Randomized Dose up/Dose down Titration Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Adult Participants with Nonsegmental Vitiligo
Kern, J. (Primary Chief Investigator (PCI))
19/12/24 → 18/12/26
Project: Research
-
Foundations in Indigenous Disaster Resilience
Williamson, B. (Primary Chief Investigator (PCI)), Reidy, N. (Chief Investigator (CI)), Connole, L. (Chief Investigator (CI)), Rogers, B. (Chief Investigator (CI)), Weir, J. (Chief Investigator (CI)), Gibbs, L. (Chief Investigator (CI)) & Quinn, P. (Chief Investigator (CI))
19/12/24 → 31/03/27
Project: Research
-
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic-Clonic Seizures
O'Brien, T. (Primary Chief Investigator (PCI))
18/12/24 → 17/12/26
Project: Research
-
A Phase 2 Randomized, Proof of Concept Study to Evaluate the Safety, Tolerability, and Efficacy of NGM120 in Pregnant Women with Severe Nausea and Vomiting (Hyperemesis Gravidarum)
Palmer, K. (Primary Chief Investigator (PCI))
18/12/24 → 17/12/29
Project: Research
-
A Phase 1b Study of JNJ-79635322 in Combination with Daratumumab or Pomalidomide for Multiple Myeloma
Low, M. (Primary Chief Investigator (PCI))
18/12/24 → 17/12/29
Project: Research
-
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ – CSU2)
Kern, J. (Primary Chief Investigator (PCI))
18/12/24 → 18/12/26
Project: Research
-
GS-US-699-7184 A Phase 2 Platform Study of Novel Combination Therapies in Participants with Head and Neck Squamous Cell Carcinoma” and GS-US-699-7184 Substudy-01, VELOCITY-HNSCC Substudy-01 A Phase 2 Study of Novel Combination Therapies in Participants With Previously Untreated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status
Alamgeer, M. (Primary Chief Investigator (PCI))
18/12/24 → 17/12/29
Project: Research
-
Artificial Intelligence.: Augmenting the Debrief of Emergency Resuscitation In-situ Simulation utilising Artificial Intelligence.
Martinez-Maldonado, R. (Primary Chief Investigator (PCI)), Connell, C. (Chief Investigator (CI)), Echeverria, V. (Chief Investigator (CI)), Chen, G. (Chief Investigator (CI)), Sevenhuysen, S. L. (Chief Investigator (CI)) & Davis, J. (Chief Investigator (CI))
18/12/24 → 18/12/27
Project: Research
-
Engaged Classrooms through Effective Classroom Management
Fox, R. (Primary Chief Investigator (PCI)) & Leif, E. (Chief Investigator (CI))
18/12/24 → 19/12/26
Project: Research
-
A Phase 1, open label single-arm two-part study to investigate safety, pharmacokinetics, and preliminary efficacy of pan-RAF/MEK glue NST-628 oral tablets in subjects with solid tumors harboring genetic alterations in the MAPK pathway and with other solid tumors
Bhave, P. (Primary Chief Investigator (PCI))
17/12/24 → 17/12/26
Project: Research
-
Corrosion triggered self-passivation of magnesium alloys
Chen, X. (Primary Chief Investigator (PCI)), Zhu, Y. (Chief Investigator (CI)), Mol, A. (Partner Investigator (PI)), Frankel, G. (Partner Investigator (PI)) & Keil, P. (Partner Investigator (PI))
16/12/24 → 15/12/27
Project: Research
-
Treatment Of early gestational diabetes Mellitus: THe follow-Up of Mothers and Babies future cardio-metabolic risk and neurodevelopment (TOMTHUMB)
Simmons, D. S. (Primary Chief Investigator (PCI)), Cheung, N. W. (Chief Investigator (CI)), Nolan, C. (Chief Investigator (CI)), Teede, H. (Chief Investigator (CI)), Sweeting, A. (Chief Investigator (CI)), Craig, M. E. (Chief Investigator (CI)), Enticott, J. (Chief Investigator (CI)), Tannous, W. (Chief Investigator (CI)), Joglekar, M. V. (Chief Investigator (CI)), Hague, W. M. (Chief Investigator (CI)), Hibbert, E. J. (Associate Investigator (AI)), Gianatti, E. J. (Associate Investigator (AI)), Wong, V. W. M. (Associate Investigator (AI)), Wong, T. (Associate Investigator (AI)), Hicks, R. (Associate Investigator (AI)), Williams, K. (Associate Investigator (AI)), Peek, M. J. (Associate Investigator (AI)), MacMillan, F. (Associate Investigator (AI)) & Duke, A. (Associate Investigator (AI))
16/12/24 → 30/06/29
Project: Research
-
Educator-child interactions and childhood social and emotional learning
Blewitt, C. (Primary Chief Investigator (PCI)), Skouteris, H. (Chief Investigator (CI)), Edwards, S. (Chief Investigator (CI)), Morris, H. (Chief Investigator (CI)) & Kirk, H. (Chief Investigator (CI))
Australian Research Council (ARC)
15/12/24 → 14/12/27
Project: Research
-
Dynamic Single-Atom Liquid Metal Nanozymes
Rahim, M. A. (Primary Chief Investigator (PCI))
Monash University – Internal Faculty Contribution
15/12/24 → 14/12/28
Project: Research
-
Workstream 2.4: Harnessing of Technology for VAW Prevention
Flynn, A. (Primary Chief Investigator (PCI)), Carlson, B. (Chief Investigator (CI)), O'Leary, P. (Chief Investigator (CI)), Eddyono, S. (Partner Investigator (PI)), Amin, S. (Partner Investigator (PI)), Powell, A. (Associate Investigator (AI)) & Kennedy, T. (Associate Investigator (AI))
13/12/24 → 13/12/27
Project: Research
-
A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV 7000 in Subjects with Refractory Focal Onset Epilepsy
O'Brien, T. (Primary Chief Investigator (PCI))
10/12/24 → 10/12/26
Project: Research
-
Abbvie MRDR Support
Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)) & Moore, E. (Chief Investigator (CI))
9/12/24 → 8/12/25
Project: Research
-
-
A randomized, double-blind, double-dummy, placebo-controlled, multicenter, Phase 3 study assessing the efficacy, safety, and tolerability of 2 doses of remibrutinib over a 68-week treatment period in adult patients with moderate to severe hidradenitis suppurativa
Kern, J. (Primary Chief Investigator (PCI)), Fernandez-Penas, P. (Chief Investigator (CI)), Nicolopoulos, J. (Chief Investigator (CI)) & Wong, C. (Chief Investigator (CI))
9/12/24 → 9/12/27
Project: Research
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn’s Disease
Moore, G. (Primary Chief Investigator (PCI))
9/12/24 → 8/12/29
Project: Research
-
A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK- 3543) versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants
Yeh, P. (Primary Chief Investigator (PCI))
9/12/24 → 8/12/29
Project: Research
-
A Phase 2, Multicenter, Single-blinded, Randomized Study to Evaluate the Pharmacokinetics and Safety of Sotatercept (MK-7962) Administered Using Either a Weight-based or Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care
Yo, S. (Primary Chief Investigator (PCI))
9/12/24 → 8/12/26
Project: Research
-
Long Foundation Fellowship
Ooi, J. (Primary Chief Investigator (PCI))
8/12/24 → 4/02/28
Project: Research
-
MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)
Hare, J. (Primary Chief Investigator (PCI))
7/12/24 → 6/12/26
Project: Research
-
SFL: Scenarios for Future Living: Putting People at the Centre of the Energy Transition
Strengers, Y. (Primary Chief Investigator (PCI)), Pink, S. (Chief Investigator (CI)), Ben-David, R. (Chief Investigator (CI)), MacGill, I. (Chief Investigator (CI)), Roberts, M. (Chief Investigator (CI)), Bruce, A. (Chief Investigator (CI)), Passey, R. (Chief Investigator (CI)), McConnell , D. (Chief Investigator (CI)), Mellick Lopes, A. (Chief Investigator (CI)), Tonkinwise, C. (Chief Investigator (CI)), Briggs, C. (Chief Investigator (CI)), Riedy, C. (Chief Investigator (CI)), Kaviani, F. (Chief Investigator (CI)), Dahlgren, K. (Chief Investigator (CI)) & Lipscombe, S. (Project Manager)
6/12/24 → 6/12/27
Project: Research
-
An Open-Label Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of BMB-101 in Adults with either classic Absence Epilepsy (with or without Eyelid Myoclonia (EEM; Jeavons syndrome), OR Developmental Epileptic Encephalopathy (DEE)
O'Brien, T. (Primary Chief Investigator (PCI)), Zentner, C. (Chief Investigator (CI)), Reutens, D. C. (Chief Investigator (CI)) & Scheffer, I. E. (Chief Investigator (CI))
5/12/24 → 5/12/26
Project: Research
-
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kapoor, M. (Primary Chief Investigator (PCI))
5/12/24 → 4/12/26
Project: Research
-
An Interventional, Open-Label, Randomized, Multicenter Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in the Neoadjuvant Setting
Muttiah, C. (Primary Chief Investigator (PCI))
5/12/24 → 5/12/26
Project: Research
-
Review of Rail Condition and Rail Grinding Cycles
Ravitharan, S. (Primary Chief Investigator (PCI)) & Lambert, R. (Chief Investigator (CI))
4/12/24 → 31/10/25
Project: Research
-
Upgrading rare earth minerals and elements using computer-aided collector design
Page, A. (Primary Chief Investigator (PCI)), Thang, S. H. (Chief Investigator (CI)), Skinner , B. (Chief Investigator (CI)), Zhao , C.-X. (Chief Investigator (CI)) & Galvin, K. P. (Chief Investigator (CI))
4/12/24 → 31/12/28
Project: Research
-
Development of stimuli responsive Bio and RAFT polymers
Ritchie, C. (Primary Chief Investigator (PCI)), Thang, S. H. (Chief Investigator (CI)), Zhao , C.-X. (Chief Investigator (CI)), Franks, G. V. (Chief Investigator (CI)) & Ata, S. (Chief Investigator (CI))
4/12/24 → 31/12/26
Project: Research
-
A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer
Moore, M. (Primary Chief Investigator (PCI))
4/12/24 → 3/12/26
Project: Research
-
Workstream 2.1: Spirituality and Institutions of Religion: Community Effects on VAW
Wendt, S. (Primary Chief Investigator (PCI)), Davies, S. E. (Chief Investigator (CI)), Humphreys, C. F. (Chief Investigator (CI)), Cripps, K. (Chief Investigator (CI)) & Vaughan, C. (Associate Investigator (AI))
3/12/24 → 3/12/27
Project: Research
-
A Phase 3, randomized, double-blind, placebo-controlled, parallelgroup, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 12 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment
Kern, J. (Primary Chief Investigator (PCI))
2/12/24 → 1/12/26
Project: Research
-
A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) or Basal Cell Carcinoma (BCC)
Kern, J. (Primary Chief Investigator (PCI))
2/12/24 → 2/12/26
Project: Research
-
Strategies for implementing alternative land tenure and use models in Australia to address the housing crisis
Alexander, J. & Murray, C.
Trustee for the Alastair Swayn Foundation
1/12/24 → 1/12/25
Project: Research
-
Controllable quantum phases in two-dimensional metal-organic nanomaterials
Schiffrin, A. (Primary Chief Investigator (PCI)), MacLeod, J. (Chief Investigator (CI)), Jelinek, P. (Partner Investigator (PI)) & Bhattacharyya, S. (Partner Investigator (PI))
1/12/24 → 30/11/27
Project: Research
-
Improving mental health and wellbeing in diverse children with disruptive disorders: A co-designed school-based early intervention involving parent-teacher collaboration
Kimonis, E. R. (Primary Chief Investigator (PCI)), Goulter, N. (Chief Investigator (CI)), Fleming, G. (Chief Investigator (CI)), Taylor, N. J. (Chief Investigator (CI)), Mihalopoulos, C. (Chief Investigator (CI)), Briggs, N. E. (Associate Investigator (AI)), Hawes, D. (Associate Investigator (AI)), Dadds, M. R. (Associate Investigator (AI)) & Nickerson, A. (Associate Investigator (AI))
1/12/24 → 30/11/26
Project: Research
-
Cardiovascular Disease (CVD) perception and knowledge among adolescents across two continents: Africa and Australia
Akombi, B. (Primary Chief Investigator (PCI)), Schutte, A. (Chief Investigator (CI)), Byaruhanga, J. (Chief Investigator (CI)), Nattabi, B. (Chief Investigator (CI)), Kalu, K. (Chief Investigator (CI)), Bello, A. (Chief Investigator (CI)), Namanda, C. (Chief Investigator (CI)), Badlangana, L. (Partner Investigator (PI)), Phegelo, M. (Partner Investigator (PI)), Adjabu, D. (Chief Investigator (CI)), Matlhagela , K. (Partner Investigator (PI)), Kilkenny, M. (Chief Investigator (CI)), Olaiya, M. (Chief Investigator (CI)), Odunaiya, N. (Chief Investigator (CI)) & Adebayo, B. (Chief Investigator (CI))
1/12/24 → 31/12/25
Project: Research
-
-
Q168: Evidence generation for side effect burden item Q168
Nolte, S. (Chief Investigator (CI))
1/12/24 → 31/05/27
Project: Research
-
A novel treatment to spare insulin and improve glucose control
Cowley, M. (Primary Chief Investigator (PCI)), Simonds, S. (Chief Investigator (CI)), Pollock, C. (Chief Investigator (CI)), Chen, X.-M. (Chief Investigator (CI)) & Cooke, I. (Associate Investigator (AI))
1/12/24 → 30/11/25
Project: Research
-
SPIA Country Study, North India - THE DYNAMICS OF AGRICULTURAL INNOVATION IN NORTH INDIA
Datt, G. (Primary Chief Investigator (PCI)), Swaminathan, M. (Chief Investigator (CI)), Tjernstrom, E. (Chief Investigator (CI)), Baksi, S. (Chief Investigator (CI)), Jacob, S. (Partner Investigator (PI)) & Jolliffe, D. (Partner Investigator (PI))
1/12/24 → 30/11/27
Project: Research
-
The project focuses on the Yiddish poetry of Abraham Sutskever (1913-2010), widely considered the greatest of the Yiddish poets.
Wolski, N. (Primary Chief Investigator (PCI))
30/11/24 → 30/11/26
Project: Research
-
Supporting children’s mathematics transition to primary school in play
Li, L. (Primary Chief Investigator (PCI)), Disney, L. (Chief Investigator (CI)) & Downton, A. (Chief Investigator (CI))
30/11/24 → 30/11/25
Project: Research
-
A First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Moore, M. (Primary Chief Investigator (PCI))
29/11/24 → 29/11/26
Project: Research